Statistics about Health, Pharma & Medtech in United States
Statistics
- Hospital utilization by highly integrated health systems in the U.S. 2014
- Nonneonatal and nonmaternal hospital stays for U.S. children 2012
- Leading hospital stays with operating room procedures for uninsured patients 2012
- Hospital stays with operating room procedures using private insurance U.S. 2012
- Hospital stays with leading operating room procedure in the U.S. using Medicaid 2012
- Hospital stays with leading female operating room procedures in the U.S. 2012
- Hospital stays with most common male operating room procedure in the U.S. 2012
- Hospital stays with operating room procedure in the U.S. by patient age group 2012
- U.S. operating room procedures with greatest average annual growth rate 2003-2012
- Number of leading operating room procedures in U.S. hospital stays 2012
- Rate of common operating room procedures in U.S. hospital stays 2012
- Stays and costs in U.S. hospitals with or without operating room procedures 2012
- Alcohol-related hospital admissions as a share of all MHSA admissions 2000-2010
- Alcohol-related emergency department visits in the U.S. from 2004-2010
- Cost savings through urgent care vs emergency department 2012
- CAGR in the U.S. urgent care market 2008-2018
- U.S. urgent care market value 2008-2018
- Annual facility charges for MS patients in the U.S. by age 2012
- Annual facility charges for multiple sclerosis patients in the U.S. by region 2012
- Share of inpatient MS cases in the U.S. by demographic 2012
- Number of retail clinics in the U.S. 2008-2018
- Customer experience - retail clinics 2012-2013
- US: average number of acquired hospitals per transaction 2007-2013
- U.S. number of hospital transactions with MSA overlap 2007-2013
- Revenue of specialty hospitals in the U.S., 2009-2014
- Revenue of psychiatric hospitals in the U.S., 2008-2013
- Revenue of hospitals in the U.S., 2009-2014
- Revenue of emergency & other outpatient care centers in the U.S., 2009-2014
- Revenue of mental health & substance abuse clinics in the U.S., 2009-2014
- Revenue of family planning & abortion clinics in the U.S., 2008-2013
- Hospital stays for patients with back problems
- Procedures among the top 5 percent of most expensive hospital stays
- Increasing U.S. hospital costs of common conditions
- U.S. Mental health and substance abuse (MHSA) discharges by major reason 2008
- U.S. extremity joint reconstruction market share by top manufacturer 2017
- U.S. extremity joint reconstruction market by body part 2017
- Company share of large joint reconstruction market U.S. 2017
- Total knee construct average pricing in the U.S. as of 2017, by supplier
- Revenue of Boiron in North America by country 2025
- LabCorp employees 2014-2025
- LabCorp basic earnings per common share 2013-2025
- LabCorp revenues 2013-2025
- LabCorp operating income 2013-2025
- LabCorp total assets 2013-2025
- Biogen research and development spending 2006-2025
- Biogen employee number 2014-2025
- Biogen's total costs and expenses 2014-2025
- Biogen earnings per share 2014-2025
- Biogen selling, general, and administrative costs 2016-2025
- Biogen revenues by type and region 2025
- Biogen net income 2007-2025
- 23andMe net income 2021-2025
- Medtronic total assets 2014-2026
- Medtronic revenue 2006-2026
- Elanco revenue by product category 2019-2025
- Percentage of Elanco revenue by product category 2020-2025
- Elanco Animal Health revenue 2015-2025
- Elanco net income 2015-2025
- Elanco research and development spending 2015-2025
- Elanco total assets 2015-2025
- Bristol-Myers Squibb's ad and promo spending 2011-2025
- Bristol-Myers Squibb's total assets 2015-2025
- Cardiology devices market revenue in the United States 2016-2030
- Life sciences export value of California 2025
- Output value of life sciences industry California 2023-2025, by sector
- U.S. as a preferred biopharma outsourcing destination 2009-2025
- Challenges limiting AI/ML adoption in drug development 2025, by companies
- Challenges limiting AI/ML adoption in drug development 2025
- Leading clinical challenges in drug development 2025
- Share of current clinical work 2025, by outsourcing model
- Factors increasing complexity in clinical trials 2025
- Estimated annual revenue loss for pharmaceuticals in the U.S. 2026-2035
- Sandoz net sales in the U.S. 2022-2025
- Medicare gross spending on GLP-1s in the U.S. 2019-2024
- Medicaid gross spending on GLP-1s in the U.S. 2019-2024
- Number of publications on patient perceptions of AI 2026
- Share of health searches returning an AI overview 2026
- Number of patents filed on medical digital twins worldwide 2015-2025
- Number of publications on medical digital twins worldwide 2015-2025
- AI/ML medical devices approved in the United States 2016-2025, by company
- LabCorp SG&A expenses as a percentage of revenues 2019-2025
- LabCorp SG&A expenses 2019-2025
- LabCorp net earnings 2013-2025
- LabCorp revenue 2021-2024, by operation
- IQVIA revenue 2016-2025, by operation
- IQVIA revenue 2013-2025
- Zoetis revenue 2021-2025, by product type
- Zoetis revenue distribution in 2025, by product category
- Zoetis revenue 2015-2025
- Zoetis research and development expenses 2017-2025
- M&A deals in the medical technology industry in the U.S. 2015-2026
- R&D licenses in the medical technology industry in the U.S. 2020-2026, by size
- Venture investment in the medical technology industry in the U.S. 2020-2026 by size
- Venture investment value in the medical technology industry in the U.S. 2020-2026
- Glyphosate-related penalty payments made by Bayer in the US 2018-2026
- Bristol-Myers Squibb's R&D expenses 2015-2025
- Merck & Co. employees 2008-2025
- Merck & Co. R&D expenditure 2006-2025
- Merck & Co. capital expenditures 2009-2025
- Merck & Co. revenues by region 2022-2025